Bright Minds Biosciences Inc (DRUG.CX)

58.56 +0.25 (+0.43%) CAD  |  CNSX  |  Jan 07, 16:00
More

Bright Minds Biosciences Enterprise Value: 403.56M for Jan. 7, 2025

Enterprise Value Chart

View Enterprise Value for DRUG.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
4Front Ventures Corp 109.91M
Green Thumb Industries Inc 2.844B
Lowell Farms Inc -0.16M
StateHouse Holdings Inc 172.76M
Vireo Growth Inc 250.42M

Enterprise Value Related Metrics

Net Income (Quarterly) -0.7734M
Total Expenses (Quarterly) 0.7913M
EPS Diluted (Quarterly) -0.17
Earnings Yield -1.18%